PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.
Professor Sir Peter Horby has been elected as a Fellow of the Royal Society, joining a cohort of the world\u2019s most eminent scientists, engineers and technologists who have made substantial contributions to the advancement of science.
Whether new research or emerging insights on current outbreaks such as mpox and H5N1, the International Pandemic Sciences Conference 2024 is inviting abstracts for presentation in our late-breaking parallel session.
A team from PSI\u2019s Policy and Practice Research Group are finalists in the University of Oxford\u2019s Vice-Chancellor Awards for outstanding research engagement.
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
Published in the journal Public Health Ethics, the research introduces an ethical framework for assessing the use of coercive antimicrobial stewardship policies to address the \u2018silent pandemic\u2019 of antimicrobial resistance.
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
Meet the presenters, panellists and chairs for the International Pandemic Sciences Conference 2024, set to take place on 1\u20132 July 2024 in Oxford and online.
The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
A new study \u2013 led by researchers at PSI \u2013 has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 \u2013 Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.
Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.
The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in \u2018Translational Science\u2019, starting in 2024. The course will teach the full journey of a product \u2018from bench to bedside\u2019 as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.
In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
![\"Scientist](\"https://www.psi.ox.ac.uk/news-and-opinion/pandemic-computer-simulations-to-guide-future-vaccine-trials/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n